Lanean...
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
MOTIVATION: Since December 2019, the newly identified coronavirus SARS-CoV-2 has caused a massive health crisis worldwide and resulted in over 70,000 COVID-19 infections so far. Clinical drugs targeting SARS-CoV-2 are urgently needed to decrease the high fatality rate of confirmed COVID-19 patients....
Gorde:
| Argitaratua izan da: | Bioinformatics |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7184403/ https://ncbi.nlm.nih.gov/pubmed/32239142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/bioinformatics/btaa224 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|